激情综合啪啪6月丁香,久久久久国产精品91福利,99精品日韩欧美在线观看,91成人午夜福利在线观看国产

上海谷博實(shí)業(yè)有限公司
初級會員 | 第15年

15026509758

當(dāng)前位置:上海谷博實(shí)業(yè)有限公司>>科研試劑>>英國Peprotech>> peprotech-300-52Recombinant Human BD-3

Recombinant Human BD-3

參  考  價(jià)面議
具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號peprotech-300-52

品       牌

廠商性質(zhì)代理商

所  在  地上海市

更新時(shí)間:2018-04-30 20:35:52瀏覽次數(shù):342次

聯(lián)系我時(shí),請告知來自 環(huán)保在線
同類優(yōu)質(zhì)產(chǎn)品更多>
重組人β-防御素3 細(xì)胞因子,重組蛋白(*,大量現(xiàn)貨)

"產(chǎn)品名稱:Human BD-3
品牌及貨號:英國peprotech 300-52
關(guān)鍵詞:BD-3,人β-防御素3
Human BD-3 其他相關(guān)重組蛋白/細(xì)胞因子產(chǎn)品:"
 

Recombinant Human BD-2 peprotech-300-49
Recombinant Human BD-1 (47a.a.) peprotech-300-51A
Recombinant Human BD-1 (36a.a.) peprotech-300-51
Recombinant Human BCMA peprotech-310-16
Recombinant Human BCA-1 (CXCL13) peprotech-300-47
Recombinant Human BAFF Receptor peprotech-310-13R
Recombinant Human BAFF peprotech-310-13
Recombinant Human Artemin peprotech-450-17
Recombinant Human APO-SAA peprotech-300-13
Recombinant Human ApoE4 peprotech-350-04
Recombinant Human ApoE3 peprotech-350-02
Recombinant Human ApoE2 peprotech-350-12
Recombinant Human ApoA-1 peprotech-350-11
Recombinant Human ANG-1 peprotech-130-06
Recombinant Human AITRL peprotech-310-22
Recombinant Human Adiponectin peprotech-450-24
Recombinant Human Activin B peprotech-120-15
Recombinant Human Activin A peprotech-120-14
Recombinant Human 4-1BBL peprotech-310-11
Recombinant Human 4-1BB Receptor peprotech-310-15
Recombinant Amino Peptidase peprotech-100-10
病毒巨噬細(xì)胞炎性蛋白2 peprotech 350-03
重組人Slit2-N peprotech 150-11
重組人細(xì)胞間粘附分子-1 peprotech 150-05
重組大鼠血管內(nèi)皮細(xì)胞生長因子 peprotech 400-31
重組大鼠腫瘤壞死因子α peprotech 400-14
重組大鼠可溶性RANK配體 peprotech 400-30
重組大鼠基質(zhì)細(xì)胞衍生因子1β peprotech 400-32B
重組大鼠基質(zhì)細(xì)胞衍生因子1α peprotech 400-32A
重組大鼠干細(xì)胞因子 peprotech 400-22
TMPRSS5 monoclonal antibody (M09), clone 2E5 抗體 Abnova-H00080975-M09
ZBP1 monoclonal antibody (M01), clone 2C10 抗體 Abnova-H00081030-M01
SLC2A10 monoclonal antibody (M02), clone 1E12 抗體 Abnova-H00081031-M02
KCNH6 monoclonal antibody (M13), clone 3D9 抗體 Abnova-H00081033-M13
COLEC12 monoclonal antibody (M01), clone 4A7 抗體 Abnova-H00081035-M01
GRINL1A monoclonal antibody (M04), clone 2E4 抗體 Abnova-H00081488-M04
PLA2G12A monoclonal antibody (M01), clone 1D11 抗體 Abnova-H00081579-M01
CDADC1 monoclonal antibody (M01), clone 1A2 抗體 Abnova-H00081602-M01
CDADC1 monoclonal antibody (M02), clone 2E8 抗體 Abnova-H00081602-M02
PVRL4 monoclonal antibody (M01A), clone 1D7 抗體 Abnova-H00081607-M01A
FIP1L1 monoclonal antibody (M05), clone 2H4 抗體 Abnova-H00081608-M05
CAB39L monoclonal antibody (M01), clone 3B11-1A4 抗體 Abnova-H00081617-M01
DIAPH3 monoclonal antibody (M01), clone 4D5 抗體 Abnova-H00081624-M01
TSC22D4 monoclonal antibody (M01), clone 1A4 抗體 Abnova-H00081628-M01
TSC22D4 monoclonal antibody (M06), clone 3C5 抗體 Abnova-H00081628-M06
TSC22D4 monoclonal antibody (M07), clone 4G7 抗體 Abnova-H00081628-M07
TSC22D4 monoclonal antibody (M08), clone 1C12 抗體 Abnova-H00081628-M08
TSSK3 monoclonal antibody (M01), clone 6G3 抗體 Abnova-H00081629-M01
TSSK3 monoclonal antibody (M02), clone 3G8 抗體 Abnova-H00081629-M02
TSSK3 monoclonal antibody (M03), clone 3F9 抗體 Abnova-H00081629-M03
TSSK3 monoclonal antibody (M05), clone 3E6 抗體 Abnova-H00081629-M05
TSSK3 monoclonal antibody (M06), clone 6H4 抗體 Abnova-H00081629-M06
TSSK3 monoclonal antibody (M07), clone 6B2 抗體 Abnova-H00081629-M07
TSSK3 monoclonal antibody (M11A), clone 3D7 抗體 Abnova-H00081629-M11A
MAP1LC3B monoclonal antibody (M01), clone 4E11 抗體 Abnova-H00081631-M01
MAP1LC3B monoclonal antibody (M02), clone 4G7 抗體 Abnova-H00081631-M02
HBLD2 monoclonal antibody (M01), clone 2E9 抗體 Abnova-H00081689-M01
ISCA1 monoclonal antibody (M02), clone 1A11 抗體 Abnova-H00081689-M02
NUAK2 monoclonal antibody (M04), clone 2F9 抗體 Abnova-H00081788-M04
RNF170 monoclonal antibody (M01), clone 2D6 抗體 Abnova-H00081790-M01
 

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗(yàn)證碼

收藏該商鋪

X
該信息已收藏!
標(biāo)簽:
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
撥打電話
在線留言
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |